Patient Participation

New investigators practicing in community-based settings bring enthusiasm and a fresh approach to clinical research, while also boosting collaboration and merging personal connection and patient-centric insights.

Designing eConsent for each study from a stakeholders’ value, not technology perspective.

In the fourth and final part of this video interview, Vincent Keunen, founder & CEO of Andaman7 looks forward and highlights some potential advancements with the use of AI.

In part 3 of this video interview, Vincent Keunen, founder & CEO of Andaman7 shares his own experience as a patient when it comes to using digital applications.

In part 2 of this video interview, Vincent Keunen, founder & CEO of Andaman7 highlights how technology vendors should be keeping the patient in mind when building solutions.

In part 1 of this video interview, Vincent Keunen, founder & CEO of Andaman7 discusses how service providers and sponsors can make the lives of patients contributing to research easier.

Webinar Date/Time: Tue, Aug 20, 2024 11:00 AM EDT

Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.

Minimizing protocol deviations is a simple, yet effective way for sites to keep trials patient-centric.

A three-part framework for a more comprehensive conceptual model of patient experience data can provide a more rounded understanding of patient experiences in clinical trials and beyond.

Webinar Date/Time: Wed, Jul 17, 2024 1:00 PM EDT

How making trial participation easier can reduce the impact on the environment.

New research updates estimated value of lost time.

Nine tips to help sites close the information and understanding gaps in their dealings with patients.

In part 1 of this video interview, Sam Liu, VP of marketing, Vivalink touches on concerns with data accuracy and security in bring-your-own-device models.

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.

A forum of prominent industry stakeholders highlights the challenges for patients in navigating the multiple legal, regulatory, and ethical barriers to cross-border participation.

Survey study assessed 58 cancer centers in the United States to identify their greatest challenges.

Webinar Date/Time: Thursday, June 6, 2024 Session 1: 9am EDT | 6am PDT | 2pm BST | 3pm CEST Session 2: 1pm EDT | 10am PDT | 6pm BST | 7pm CEST

Analysis of randomized clinical trial for migraine sought to determine whether there were differences between outcomes from patients assigned to roles and those as healthy controls.

In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.

Harnessing advances in digital health technologies for a more precision-measured approach.

The potential of personal health records to bridge the gap between research and care.

Five proactive steps industry can take to optimize a patient's clinical trial experience.

Following a webinar on the use of a medical device in a migraine clinical trial, Mowlem caught up with ACT to discuss her biggest takeaways and what she is currently seeing in the digital trials space.